NeuroOne to Report Fiscal Second Quarter 2026 Financial Results on May 12

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company focused on surgical solutions for neurological disorders, announced it will release its fiscal second quarter 2026 financial results on Tuesday, May 12, 2026, before market open. The company will host a conference call at 8:30 a.m. Eastern time to discuss the results and provide a corporate update.

The earnings call will be accessible via telephone at 888-506-0062 (toll-free U.S.) or 973-528-0011 (international) using participant access code 224785. A live webcast will also be available at NMTC FY Q2 2026 Earnings Call Webcast. Participants are encouraged to join at least five minutes before the start time.

A replay of the call will be available until May 26, 2026, by dialing 877-481-4010 (U.S.) or 919-882-2331 (international) with replay passcode 53948. A webcast replay will remain accessible via the same link until May 12, 2027.

NeuroOne markets a minimally invasive electrode technology platform with four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions aim to reduce hospitalizations and surgeries, lower costs, and improve outcomes by combining diagnostic and therapeutic functions. The company also has research and development programs in drug delivery, basivertebral nerve ablation, and spinal cord stimulation.

The financial results for the quarter ended March 31, 2026, will provide insight into the company’s performance and progress in its pipeline. Investors and analysts will have the opportunity to ask questions during the Q&A session following management’s remarks. For more information about NeuroOne, visit nmtc1.com.

This announcement is significant as it gives stakeholders a chance to assess the company’s financial health and strategic direction in the competitive medical technology space. NeuroOne’s focus on neurological disorders addresses a growing need for advanced surgical options, and the quarterly report may offer clues about future growth and market adoption of its products.

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is NeuroOne to Report Fiscal Second Quarter 2026 Financial Results on May 12.

The post NeuroOne to Report Fiscal Second Quarter 2026 Financial Results on May 12 appeared first on citybuzz.